$CATX
Perspective Therapeutics, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024125399 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $2.185M
YoY Change 27.26%
Cost Of Revenue $1.447M
YoY Change 11.05%
Gross Profit $738.0K
YoY Change 78.26%
Gross Profit Margin 33.78%
Selling, General & Admin $5.551M
YoY Change 41.82%
% of Gross Profit 752.17%
Research & Development $12.03M $5.721M
YoY Change 110.24% 708.05%
% of Gross Profit 775.2%
Depreciation & Amortization $269.0K
YoY Change 295.59%
% of Gross Profit 36.45%
Operating Expenses $19.00M $11.27M
YoY Change 68.59% 143.88%
Operating Profit -$18.63M -$10.53M
YoY Change 76.89% 150.33%
Interest Expense $14.00K
YoY Change -90.0%
% of Operating Profit
Other Income/Expense, Net $3.512M $178.0K
YoY Change 1873.03% 27.14%
Pretax Income -$15.12M -$10.36M
YoY Change 46.02% 154.57%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$15.12M -$10.36M
YoY Change 46.02% 154.57%
Net Earnings / Revenue -473.96%
Basic Earnings Per Share -$0.21 -$0.04
Diluted Earnings Per Share -$0.21 -$0.04
COMMON SHARES
Basic Shares Outstanding 67.59M 67.43M 280.6M
Diluted Shares Outstanding 70.63M 28.06M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.98M
YoY Change -66.77%
Cash & Equivalents $226.4M $18.00M
Short-Term Investments
Other Short-Term Assets $961.0K
YoY Change 45.17%
Inventory $1.013M
Prepaid Expenses
Receivables $217.0K $1.731M
Other Receivables $0.00
Total Short-Term Assets $270.2M $21.69M
YoY Change 1145.72% -62.31%
LONG-TERM ASSETS
Property, Plant & Equipment $43.79M $7.012M
YoY Change 524.53% 250.78%
Goodwill $24.10M $27.32M
YoY Change -11.78%
Intangibles $50.00M
YoY Change
Long-Term Investments
YoY Change
Other Assets $694.0K $551.0K
YoY Change 25.95% 445.54%
Total Long-Term Assets $121.0M $88.83M
YoY Change 36.19% 1677.31%
TOTAL ASSETS
Total Short-Term Assets $270.2M $21.69M
Total Long-Term Assets $121.0M $88.83M
Total Assets $391.2M $110.5M
YoY Change 253.93% 76.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.867M
YoY Change 54.99%
Accrued Expenses $4.200M
YoY Change 178.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $48.00K
YoY Change
Total Short-Term Liabilities $28.14M $8.115M
YoY Change 246.8% 102.82%
LONG-TERM LIABILITIES
Long-Term Debt $1.689M
YoY Change
Other Long-Term Liabilities $33.00K $1.944M
YoY Change -98.3% 132.81%
Total Long-Term Liabilities $33.00K $3.633M
YoY Change -99.09% 335.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.14M $8.115M
Total Long-Term Liabilities $33.00K $3.633M
Total Liabilities $62.68M $11.75M
YoY Change 433.55% 142.93%
SHAREHOLDERS EQUITY
Retained Earnings -$191.6M -$127.8M
YoY Change 49.92% 24.48%
Common Stock $520.0M $226.5M
YoY Change 129.55% 41.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $328.5M $98.77M
YoY Change
Total Liabilities & Shareholders Equity $391.2M $110.5M
YoY Change 253.93% 76.72%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$15.12M -$10.36M
YoY Change 46.02% 154.57%
Depreciation, Depletion And Amortization $269.0K
YoY Change 295.59%
Cash From Operating Activities -$10.11M
YoY Change 473.45%
INVESTING ACTIVITIES
Capital Expenditures $227.0K
YoY Change 152.22%
Acquisitions
YoY Change
Other Investing Activities $3.000K
YoY Change -100.01%
Cash From Investing Activities -$227.0K
YoY Change -99.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.000K
YoY Change -96.43%
NET CHANGE
Cash From Operating Activities -10.11M
Cash From Investing Activities -227.0K
Cash From Financing Activities 1.000K
Net Change In Cash -10.34M
YoY Change -71.99%
FREE CASH FLOW
Cash From Operating Activities -$10.11M
Capital Expenditures $227.0K
Free Cash Flow -$10.34M
YoY Change 457.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-59000
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0
CY2024Q3 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-15122000
CY2023Q3 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-10356000
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-39110000
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-32333000
CY2024Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10500000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-15122000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10356000
us-gaap Net Income Loss
NetIncomeLoss
-39110000
us-gaap Net Income Loss
NetIncomeLoss
-21833000
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.21
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.21
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.34
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.34
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.61
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.61
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.68
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.68
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.03
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.03
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.15
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.15
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70629000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70629000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28055000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28055000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62293000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62293000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26323000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26323000
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
us-gaap Net Income Loss
NetIncomeLoss
-39110000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000728387
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33407
dei Entity Registrant Name
EntityRegistrantName
PERSPECTIVE THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1458152
dei Entity Address Address Line1
EntityAddressAddressLine1
2401 Elliott Avenue, Suite 320
dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98121
dei City Area Code
CityAreaCode
206
dei Local Phone Number
LocalPhoneNumber
676-0900
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
CATX
us-gaap Net Income Loss
NetIncomeLoss
-21833000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-39000
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67587540
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
226443000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9238000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
41404000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
592000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
650000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
217000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1165000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2108000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1133000
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5301000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
270172000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
16837000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43792000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5576000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2433000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
747000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2024Q3 us-gaap Goodwill
Goodwill
24062000
CY2023Q4 us-gaap Goodwill
Goodwill
24062000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
694000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
487000
CY2024Q3 us-gaap Assets
Assets
391153000
CY2023Q4 us-gaap Assets
Assets
97891000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
21813000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6909000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
903000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
46000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3976000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3588000
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
51000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
49000
CY2024Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
1400000
CY2023Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
0
CY2024Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
5072000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
28143000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15664000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1676000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
780000
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
1638000
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1676000
CY2024Q3 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
26600000
CY2023Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
0
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4592000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4592000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2024Q3 us-gaap Liabilities
Liabilities
62682000
CY2023Q4 us-gaap Liabilities
Liabilities
22712000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67562781
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67562781
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28180985
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28180985
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
67000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
28000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
519954000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
227591000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-191550000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152440000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
328471000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
75179000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
391153000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97891000
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
CY2024Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
369000
CY2023Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
276000
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
1220000
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
1097000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12028000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5552000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
catx Noncash Expense Lease
NoncashExpenseLease
100000
catx Noncash Expense Lease
NoncashExpenseLease
35000
us-gaap Depreciation
Depreciation
1585000
us-gaap Depreciation
Depreciation
684000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28755000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14231000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6975000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4474000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18367000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16124000
CY2024Q3 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0
CY2023Q3 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
15000
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-22000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
19003000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
10026000
us-gaap Operating Expenses
OperatingExpenses
47122000
us-gaap Operating Expenses
OperatingExpenses
30362000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18634000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9750000
us-gaap Operating Income Loss
OperatingIncomeLoss
-45902000
us-gaap Operating Income Loss
OperatingIncomeLoss
-29265000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3581000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
204000
us-gaap Investment Income Interest
InvestmentIncomeInterest
7868000
us-gaap Investment Income Interest
InvestmentIncomeInterest
872000
CY2024Q3 catx Interest And Other Expense
InterestAndOtherExpense
69000
CY2023Q3 catx Interest And Other Expense
InterestAndOtherExpense
14000
catx Interest And Other Expense
InterestAndOtherExpense
121000
catx Interest And Other Expense
InterestAndOtherExpense
58000
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3512000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
178000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7741000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
802000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15122000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9572000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38161000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28463000
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-784000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-890000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-3870000
CY2024Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0
us-gaap Inventory Write Down
InventoryWriteDown
0
us-gaap Inventory Write Down
InventoryWriteDown
298000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-22000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
12000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
30000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
0
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
26000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12000
catx Accrued Interest On Short Term Investments
AccruedInterestOnShortTermInvestments
899000
catx Accrued Interest On Short Term Investments
AccruedInterestOnShortTermInvestments
0
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-58000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
15000
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-59000
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0
us-gaap Share Based Compensation
ShareBasedCompensation
3327000
us-gaap Share Based Compensation
ShareBasedCompensation
3018000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10500000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-890000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
368000
catx Increase Decrease In Inventory Related To Discontinued Operations
IncreaseDecreaseInInventoryRelatedToDiscontinuedOperations
-11000
catx Increase Decrease In Inventory Related To Discontinued Operations
IncreaseDecreaseInInventoryRelatedToDiscontinuedOperations
-257000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
975000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14937000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-683000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
28000000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
388000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1100000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8312000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27905000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39800000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
983000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
24000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
18000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
38225000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
22764000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
78730000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
2699000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80329000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24462000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
36000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
56000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
125000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
896000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
554000
catx Proceeds From Issuance Of Common Stock And Prefunded Warrants Net
ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsNet
288055000
catx Proceeds From Issuance Of Common Stock And Prefunded Warrants Net
ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsNet
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
65000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
289040000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
433000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
217023000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3010000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9420000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21175000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
226443000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18165000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
226443000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17983000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
226443000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18165000
catx Recognition Of Operating Lease Liability And Right Of Use Asset
RecognitionOfOperatingLeaseLiabilityAndRightOfUseAsset
2115000
catx Recognition Of Operating Lease Liability And Right Of Use Asset
RecognitionOfOperatingLeaseLiabilityAndRightOfUseAsset
811000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
16518000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0
catx Noncash Or Part Noncash Acquisition Value Of Assets Acquired Including Goodwill
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquiredIncludingGoodwill
0
catx Noncash Or Part Noncash Acquisition Value Of Assets Acquired Including Goodwill
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquiredIncludingGoodwill
85885000
us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
13654507
us-gaap Stock Issued1
StockIssued1
0
us-gaap Stock Issued1
StockIssued1
54618000
catx Noncash Or Part Noncash Acquisition Assumption Of Stock Options And Warrants
NoncashOrPartNoncashAcquisitionAssumptionOfStockOptionsAndWarrants
0
catx Noncash Or Part Noncash Acquisition Assumption Of Stock Options And Warrants
NoncashOrPartNoncashAcquisitionAssumptionOfStockOptionsAndWarrants
-7836000
catx Noncash Or Part Noncash Acquisition Notes Receivable And Accrued Interest Forgiven
NoncashOrPartNoncashAcquisitionNotesReceivableAndAccruedInterestForgiven
0
catx Noncash Or Part Noncash Acquisition Notes Receivable And Accrued Interest Forgiven
NoncashOrPartNoncashAcquisitionNotesReceivableAndAccruedInterestForgiven
-6171000
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
54642000
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
54553000
CY2023Q1 catx Adjustments To Additional Paid In Capital Assumption Of Stock Options And Warrants At Fair Value
AdjustmentsToAdditionalPaidInCapitalAssumptionOfStockOptionsAndWarrantsAtFairValue
7836000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1368000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-371000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
118028000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
532000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1199000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11106000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
108653000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
22000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
451000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10356000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
98770000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
75179000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
126000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-12284000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
229891000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
128000
CY2024Q2 catx Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
123000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
719000
CY2024Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-1000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-11704000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
340997000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
642000
CY2024Q3 catx Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
2000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1952000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-15122000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
328471000
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
267800000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-191600000
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
267800000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition to the discontinued operations discussed above, during the first quarter of 2024, the Company made certain reclassifications to prior period amounts in the condensed consolidated financial statements and accompanying notes to conform to the current period presentation. The reclassification of these items had no impact on net loss, financial position or cash flows in the current or prior periods. Specifically, accrued payroll and related taxes and accrued vacation were combined to create accrued personnel, and accrued protocol expense and accrued waste disposal were included in accounts payable and accrued expenses, all of which are presented on the condensed consolidated balance sheets and condensed consolidated statement of cash flows.</span></p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7668000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5044000
CY2023Q4 catx Maximum Amount Of Securities Offer And Sell
MaximumAmountOfSecuritiesOfferAndSell
200000000
CY2024Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2023Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2024Q3 us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
49000000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
46046000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6245000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2254000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
669000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43792000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5576000
CY2024Q3 us-gaap Goodwill
Goodwill
24100000
CY2023Q4 us-gaap Goodwill
Goodwill
24100000
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2024Q3 catx Indefinitelived Intangible Assets Accumulated Amortization
IndefinitelivedIntangibleAssetsAccumulatedAmortization
0
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2023Q4 catx Indefinitelived Intangible Assets Accumulated Amortization
IndefinitelivedIntangibleAssetsAccumulatedAmortization
0
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1952000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
418000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3161000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2450000
us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
6
CY2023Q4 catx Aggregate Maximum Estimate Settlement Amount
AggregateMaximumEstimateSettlementAmount
200000
CY2024Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P52M
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
us-gaap Operating Lease Expense
OperatingLeaseExpense
500000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000
us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
245000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1112000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
647000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
493000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
443000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2940000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
361000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2579000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
903000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1676000
CY2024Q3 catx Estimated Hazardous Waste Removal Liability
EstimatedHazardousWasteRemovalLiability
500000
CY2023Q4 catx Estimated Hazardous Waste Removal Liability
EstimatedHazardousWasteRemovalLiability
500000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
13000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
52000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
55000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1569000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1689000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 catx Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 catx Non Rule10 B51 Arrangement Modified Flag
NonRule10B51ArrangementModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-125399-index-headers.html Edgar Link pending
0000950170-24-125399-index.html Edgar Link pending
0000950170-24-125399.txt Edgar Link pending
0000950170-24-125399-xbrl.zip Edgar Link pending
catx-20240930.htm Edgar Link pending
catx-20240930.xsd Edgar Link pending
catx-ex10_1.htm Edgar Link pending
catx-ex31_1.htm Edgar Link pending
catx-ex31_2.htm Edgar Link pending
catx-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img49486978_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
catx-20240930_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable